Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry
暂无分享,去创建一个
Daniel S Spellman | R. Hendrickson | Matthew T. Mazur | N. Yates | Helene L Cardasis | Helene L. Cardasis | Andyun-Fan Liaw | Nathan A Yates | Ronald C Hendrickson | Matthew T Mazur | Andy Liaw | Ronald C. Hendrickson
[1] W. Blackstock,et al. Proteomics: quantitative and physical mapping of cellular proteins. , 1999, Trends in biotechnology.
[2] N. Kelleher,et al. Decoding protein modifications using top-down mass spectrometry , 2007, Nature Methods.
[3] J. Heinecke. The HDL proteome: a marker–and perhaps mediator–of coronary artery disease Published, JLR Papers in Press, December 5, 2008. , 2009, Journal of Lipid Research.
[4] Shu Zheng,et al. Discovery and identification of potential biomarkers of papillary thyroid carcinoma , 2009, Molecular Cancer.
[5] G. McAlister,et al. A proteomics grade electron transfer dissociation-enabled hybrid linear ion trap-orbitrap mass spectrometer. , 2008, Journal of proteome research.
[6] Lewis Y. Geer,et al. Analysis of intact proteins on a chromatographic time scale by electron transfer dissociation tandem mass spectrometry. , 2007, International journal of mass spectrometry.
[7] Yong-Bin Kim,et al. ProSight PTM: an integrated environment for protein identification and characterization by top-down mass spectrometry , 2004, Nucleic Acids Res..
[8] F W McLafferty,et al. Biomolecule Mass Spectrometry , 1999, Science.
[9] A. Tall,et al. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. , 2007, The Journal of clinical investigation.
[10] John R. Yates,et al. The biological impact of mass-spectrometry-based proteomics , 2007, Nature.
[11] Matthew C Wiener,et al. Quantitative analysis of complex peptide mixtures using FTMS and differential mass spectrometry , 2007, Journal of the American Society for Mass Spectrometry.
[12] R. Hendrickson,et al. Quantitative analysis of histone deacetylase-1 selective histone modifications by differential mass spectrometry. , 2008, Journal of proteome research.
[13] R. Hegele,et al. Is raising HDL a futile strategy for atheroprotection? , 2008, Nature Reviews Drug Discovery.
[14] D. Hochstrasser,et al. From Proteins to Proteomes: Large Scale Protein Identification by Two-Dimensional Electrophoresis and Arnino Acid Analysis , 1996, Bio/Technology.
[15] M. Mann,et al. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.
[16] G. Miller,et al. PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.
[17] J. Yates,et al. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. , 2004, Analytical chemistry.
[18] P. K. Smith,et al. Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.
[19] D. Thelle,et al. THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.
[20] Subramaniam Pennathur,et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.
[21] H. Eder,et al. Protein-lipid relationships in human plasma. I. In normal individuals. , 1951, The American journal of medicine.
[22] T. Ogura,et al. Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation. , 1987, Journal of lipid research.
[23] A. Scanu. Studies on the conformation of human serum high-density lipoproteins HDL2 and HDL3. , 1965, Proceedings of the National Academy of Sciences of the United States of America.
[24] M C Hjortland,et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.
[25] G. Assmann,et al. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. , 2003, Atherosclerosis.
[26] K. Parker,et al. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.
[27] A. Olsson. Is high HDL cholesterol always good? , 2009, Annals of medicine.
[28] A. Scanu,et al. HDL: bridging past and present with a look at the future , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] H. Eder,et al. Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions. , 1951, The American journal of medicine.
[30] G. McAlister,et al. Implementation of electron-transfer dissociation on a hybrid linear ion trap-orbitrap mass spectrometer. , 2007, Analytical chemistry.
[31] J. O’Connell,et al. A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection , 2008, Science.
[32] A. Tall,et al. ATP‐binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] M. Mann,et al. Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast , 2008, Nature.
[34] R. Aebersold,et al. Mass Spectrometry and Protein Analysis , 2006, Science.
[35] Hongling Han,et al. Electron transfer dissociation of iTRAQ labeled peptide ions. , 2008, Journal of proteome research.
[36] E. Arnesen,et al. The Tromsø Heart Study , 1983 .
[37] T. Shaler,et al. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. , 2003, Analytical chemistry.
[38] F. McLafferty,et al. Electron capture dissociation for structural characterization of multiply charged protein cations. , 2000, Analytical chemistry.
[39] J. Shabanowitz,et al. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Mann,et al. Analysis of proteins and proteomes by mass spectrometry. , 2001, Annual review of biochemistry.
[41] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[42] C. Paweletz,et al. Surface enhanced laser desorption ionization spectrometry reveals biomarkers for drug treatment but not dose , 2006, Proteomics.
[43] F. McLafferty,et al. Top down versus bottom up protein characterization by tandem high- resolution mass spectrometry , 1999 .
[44] Guilong Cheng,et al. Mass spectrometry of peptides and proteins. , 2005, Methods.
[45] Farhad Rezaee,et al. Proteomic analysis of high‐density lipoprotein , 2006, Proteomics.
[46] Jingyuan Deng,et al. Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. , 2010, Journal of proteome research.
[47] Matthew C Wiener,et al. Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry. , 2010, Journal of proteome research.
[48] B. Warrack,et al. A tris (2-carboxyethyl) phosphine (TCEP) related cleavage on cysteine-containing proteins , 2010, Journal of the American Society for Mass Spectrometry.
[49] F W McLafferty,et al. Localization of labile posttranslational modifications by electron capture dissociation: the case of gamma-carboxyglutamic acid. , 1999, Analytical chemistry.
[50] F. McLafferty,et al. Electron Capture Dissociation of Multiply Charged Protein Cations. A Nonergodic Process , 1998 .
[51] David L. Tabb,et al. A proteomic view of the Plasmodium falciparum life cycle , 2002, Nature.
[52] M. Mann,et al. Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). , 2003, Journal of proteome research.
[53] Lukas N. Mueller,et al. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. , 2008, Journal of proteome research.
[54] G. Bernard,et al. O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. , 2009, Journal of proteome research.
[55] Kyriakos E Kypreos. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia. , 2008, Biochemistry.
[56] J. Yates,et al. Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.
[57] B. Ueberheide,et al. The utility of ETD mass spectrometry in proteomic analysis. , 2006, Biochimica et biophysica acta.
[58] S. Gygi,et al. Quantitative Cancer Proteomics: Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) as a Tool for Prostate Cancer Research*S , 2004, Molecular & Cellular Proteomics.
[59] R. Hendrickson,et al. Differential mass spectrometry of rat plasma reveals proteins that are responsive to 17beta-estradiol and a selective estrogen receptor modulator PPT. , 2008, Journal of proteome research.
[60] Yong-Bin Kim,et al. ProSight PTM 2.0: improved protein identification and characterization for top down mass spectrometry , 2007, Nucleic Acids Res..
[61] S. Goldstein,et al. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. , 1981, Journal of lipid research.
[62] M. Wiener,et al. Differential mass spectrometry: a label-free LC-MS method for finding significant differences in complex peptide and protein mixtures. , 2004, Analytical chemistry.